Press release
27.05.2021 To the attention of interested persons Insufficient data on use of inhaled corticosteroids to treat COVID-19 download document …
Press release
21.05.2021 To the attention of interested persons EMA issues advice on use of sotrovimab (VIR-7831) for treating COVID-19. download document […]
Press release
21.05.2021 To the attention of interested persons Vaxzevria: further advice on blood clots and low blood platelets. download document …
Important notification
18.05.2021 To the attention of stakeholders The unique identification system of medical devices (UDI), in accordance with Regulations (EU) 2017/745 […]
Press release
07.05.2021 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 May 2021. download […]
Press release
07.05.2021 To the attention of interested persons EMA starts rolling review of sotrovimab (VIR-7831) for COVID-19. download document …
Press release
04.05.2021 To the attention of interested persons EMA starts evaluating use of Olumiant in hospitalised COVID-19 patients requiring supplemental oxygen. […]
Press release
28.04.2021 To the attention of interested persons AstraZeneca’s COVID-19 vaccine: benefits and risks in context. download document …
Press release
28.04.2021 To the attention of interested persons Annex to Vaxzevria Art.5.3 – Visual risk contextualisation. download document …
Press release
21.04.2021 To the attention of interested persons COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual […]